Company Filing History:
3 out of 417 
3 out of 12 Years Active: 2023-2025
Title: The Innovative Contributions of Ryousuke Irie
Introduction
Ryousuke Irie is a notable inventor based in Japan, recognized for his work in the pharmaceutical field. He has made significant contributions to the development of formulations aimed at treating hyperproliferative disorders. His expertise in this area has led to innovative approaches in drug formulation.
Latest Patents
Although Ryousuke Irie currently holds no patents, his work on the formulation of enzalutamide is noteworthy. This formulation involves a solid dispersion containing amorphous enzalutamide and hydroxypropyl methylcellulose acetate succinate. The application of this formulation is particularly relevant in the treatment of hyperproliferative disorders.
Career Highlights
Throughout his career, Ryousuke Irie has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Astellas Pharma GmbH and Medivation Prostate Therapeutics, Inc. His experience in these organizations has contributed to his understanding of drug development and formulation.
Collaborations
Ryousuke Irie's collaborations with leading pharmaceutical companies have allowed him to leverage resources and expertise in the field. His work with Astellas Pharma and Medivation Prostate Therapeutics has facilitated advancements in drug formulations, particularly in oncology.
Conclusion
Ryousuke Irie is a dedicated inventor whose contributions to pharmaceutical formulations are significant. His